annual SGA:
$172.03M-$23.01M(-11.80%)Summary
- As of today (June 1, 2025), AUPH annual SGA is $172.03 million, with the most recent change of -$23.01 million (-11.80%) on December 31, 2024.
- During the last 3 years, AUPH annual SGA has fallen by -$1.51 million (-0.87%).
- AUPH annual SGA is now -12.40% below its all-time high of $196.37 million, reached on December 31, 2022.
Performance
AUPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$20.34M-$24.92M(-55.06%)Summary
- As of today (June 1, 2025), AUPH quarterly SGA is $20.34 million, with the most recent change of -$24.92 million (-55.06%) on March 31, 2025.
- Over the past year, AUPH quarterly SGA has dropped by -$27.36 million (-57.36%).
- AUPH quarterly SGA is now -66.45% below its all-time high of $60.62 million, reached on December 31, 2023.
Performance
AUPH quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$3.74B+$39.84M(+1.05%)Summary
- As of today (June 1, 2025), AUPH TTM SGA is -$3.74 billion, with the most recent change of +$39.84 million (+1.05%) on March 31, 2025.
- Over the past year, AUPH TTM SGA has dropped by -$3.94 billion (-2004.07%).
- AUPH TTM SGA is now -67875.43% below its all-time high of -$5.50 million.
Performance
AUPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AUPH Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -11.8% | -57.4% | -2004.1% |
3 y3 years | -0.9% | -55.0% | -2190.3% |
5 y5 years | +670.1% | +84.0% | -10000.0% |
AUPH Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -12.4% | at low | -66.5% | at low | -27.0% | +1.2% |
5 y | 5-year | -12.4% | +670.1% | -66.5% | +84.0% | -117.8% | +1.2% |
alltime | all time | -12.4% | >+9999.0% | -66.5% | >+9999.0% | <-9999.0% | +1.2% |
AUPH Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $20.34M(-55.1%) | $147.51M(-15.6%) |
Dec 2024 | $172.03M(-11.8%) | $45.26M(+14.2%) | $174.87M(-8.1%) |
Sep 2024 | - | $39.64M(-6.2%) | $190.23M(-2.5%) |
Jun 2024 | - | $42.28M(-11.4%) | $195.07M(-0.7%) |
Mar 2024 | - | $47.70M(-21.3%) | $196.43M(+0.7%) |
Dec 2023 | $195.04M(-0.7%) | $60.62M(+36.3%) | $195.04M(+7.2%) |
Sep 2023 | - | $44.48M(+1.9%) | $181.89M(-4.1%) |
Jun 2023 | - | $43.64M(-5.7%) | $189.59M(-4.0%) |
Mar 2023 | - | $46.30M(-2.5%) | $197.48M(+0.6%) |
Dec 2022 | $196.37M(+13.2%) | $47.47M(-9.0%) | $196.37M(+1.4%) |
Sep 2022 | - | $52.17M(+1.2%) | $193.66M(+4.0%) |
Jun 2022 | - | $51.53M(+14.0%) | $186.14M(+4.0%) |
Mar 2022 | - | $45.20M(+1.0%) | $178.93M(+3.1%) |
Dec 2021 | $173.54M(+78.4%) | $44.76M(+0.3%) | $173.54M(+2.8%) |
Sep 2021 | - | $44.65M(+0.7%) | $168.84M(+9.0%) |
Jun 2021 | - | $44.32M(+11.3%) | $154.90M(+22.9%) |
Mar 2021 | - | $39.80M(-0.7%) | $126.02M(+29.6%) |
Dec 2020 | $97.27M(+335.5%) | $40.07M(+30.5%) | $97.27M(+50.5%) |
Sep 2020 | - | $30.70M(+98.7%) | $64.63M(+61.6%) |
Jun 2020 | - | $15.45M(+39.8%) | $39.99M(+35.6%) |
Mar 2020 | - | $11.05M(+48.8%) | $29.49M(+32.0%) |
Dec 2019 | $22.34M(+63.1%) | $7.43M(+22.6%) | $22.34M(+21.2%) |
Sep 2019 | - | $6.06M(+22.5%) | $18.43M(+20.5%) |
Jun 2019 | - | $4.95M(+26.8%) | $15.29M(+10.8%) |
Mar 2019 | - | $3.90M(+10.9%) | $13.80M(+0.8%) |
Dec 2018 | $13.69M(+13.2%) | $3.52M(+20.4%) | $13.69M(+3.0%) |
Sep 2018 | - | $2.92M(-15.6%) | $13.29M(+2.1%) |
Jun 2018 | - | $3.46M(-8.7%) | $13.02M(+4.5%) |
Mar 2018 | - | $3.79M(+21.6%) | $12.46M(+3.0%) |
Dec 2017 | $12.10M(+73.5%) | $3.12M(+17.7%) | $12.10M(+8.0%) |
Sep 2017 | - | $2.65M(-8.7%) | $11.21M(+9.1%) |
Jun 2017 | - | $2.90M(-15.3%) | $10.27M(+11.6%) |
Mar 2017 | - | $3.43M(+53.9%) | $9.21M(+32.1%) |
Dec 2016 | $6.97M(+11.3%) | $2.23M(+29.8%) | $6.97M(+10.5%) |
Sep 2016 | - | $1.72M(-6.5%) | $6.31M(+5.6%) |
Jun 2016 | - | $1.83M(+53.9%) | $5.97M(+7.6%) |
Mar 2016 | - | $1.19M(-23.8%) | $5.55M(-11.4%) |
Dec 2015 | $6.26M(-9.1%) | $1.56M(+13.3%) | $6.26M(+2.7%) |
Sep 2015 | - | $1.38M(-2.4%) | $6.10M(-0.4%) |
Jun 2015 | - | $1.41M(-25.8%) | $6.12M(-4.7%) |
Mar 2015 | - | $1.91M(+36.2%) | $6.42M(-6.8%) |
Dec 2014 | $6.89M(+199.8%) | $1.40M(-0.4%) | $6.89M(+9.2%) |
Sep 2014 | - | $1.41M(-18.0%) | $6.31M(+16.9%) |
Jun 2014 | - | $1.71M(-27.8%) | $5.40M(+29.3%) |
Mar 2014 | - | $2.37M(+189.0%) | $4.18M(+81.8%) |
Dec 2013 | $2.30M(-41.1%) | $821.00K(+66.9%) | $2.30M(-3.4%) |
Sep 2013 | - | $492.00K(+0.2%) | $2.38M(-17.3%) |
Jun 2013 | - | $491.00K(-0.6%) | $2.88M(-14.4%) |
Mar 2013 | - | $494.00K(-45.3%) | $3.36M(-12.8%) |
Dec 2012 | $3.90M(+42.2%) | $902.90K(-8.8%) | $3.86M(+3.5%) |
Sep 2012 | - | $989.60K(+1.6%) | $3.72M(+9.8%) |
Jun 2012 | - | $974.30K(-1.4%) | $3.39M(+9.6%) |
Mar 2012 | - | $988.30K(+28.1%) | $3.09M(+9.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $2.74M(-16.0%) | $771.70K(+17.4%) | $2.84M(-11.8%) |
Sep 2011 | - | $657.20K(-3.0%) | $3.21M(-3.0%) |
Jun 2011 | - | $677.30K(-7.2%) | $3.31M(+1.1%) |
Mar 2011 | - | $729.50K(-36.6%) | $3.28M(+0.4%) |
Dec 2010 | $3.27M(-8.0%) | $1.15M(+52.3%) | $3.26M(+14.7%) |
Sep 2010 | - | $755.00K(+17.5%) | $2.85M(+4.5%) |
Jun 2010 | - | $642.30K(-10.3%) | $2.72M(-15.3%) |
Mar 2010 | - | $716.10K(-2.2%) | $3.21M(-2.8%) |
Dec 2009 | $3.55M(-21.8%) | $732.00K(+15.9%) | $3.31M(+6.0%) |
Sep 2009 | - | $631.50K(-44.2%) | $3.12M(-13.0%) |
Jun 2009 | - | $1.13M(+39.8%) | $3.58M(-10.5%) |
Mar 2009 | - | $810.20K(+48.4%) | $4.01M(-13.6%) |
Dec 2008 | $4.54M(-20.5%) | $546.00K(-50.2%) | $4.64M(-11.9%) |
Sep 2008 | - | $1.10M(-29.5%) | $5.27M(-4.7%) |
Jun 2008 | - | $1.56M(+7.9%) | $5.53M(+3.5%) |
Mar 2008 | - | $1.44M(+22.8%) | $5.34M(-4.0%) |
Dec 2007 | $5.71M(-7.8%) | $1.17M(-13.4%) | $5.56M(-5.7%) |
Sep 2007 | - | $1.35M(-1.0%) | $5.89M(-1.7%) |
Jun 2007 | - | $1.37M(-17.7%) | $6.00M(-5.2%) |
Mar 2007 | - | $1.66M(+10.2%) | $6.33M(+0.9%) |
Dec 2006 | $6.19M(-36.7%) | $1.51M(+3.5%) | $6.27M(-29.9%) |
Sep 2006 | - | $1.46M(-14.2%) | $8.95M(-1.9%) |
Jun 2006 | - | $1.70M(+5.7%) | $9.13M(+1.6%) |
Mar 2006 | - | $1.61M(-61.6%) | $8.98M(-12.2%) |
Dec 2005 | $9.78M(+24.6%) | $4.18M(+156.1%) | $10.22M(+26.0%) |
Sep 2005 | - | $1.63M(+5.2%) | $8.11M(+1.8%) |
Jun 2005 | - | $1.55M(-45.5%) | $7.97M(-9.3%) |
Mar 2005 | - | $2.85M(+37.5%) | $8.79M(+15.0%) |
Dec 2004 | $7.85M(-5.8%) | $2.07M(+38.8%) | $7.65M(-2.2%) |
Sep 2004 | - | $1.49M(-37.1%) | $7.82M(-7.7%) |
Jun 2004 | - | $2.37M(+39.4%) | $8.48M(-1.8%) |
Mar 2004 | - | $1.70M(-24.3%) | $8.63M(+4.8%) |
Dec 2003 | $8.33M(+47.4%) | $2.25M(+4.7%) | $8.23M(+4.7%) |
Sep 2003 | - | $2.15M(-15.0%) | $7.86M(+16.9%) |
Jun 2003 | - | $2.53M(+93.7%) | $6.72M(+11.1%) |
Mar 2003 | - | $1.30M(-30.5%) | $6.05M(+5.3%) |
Dec 2002 | $5.65M(+85.1%) | $1.88M(+85.5%) | $5.74M(+48.6%) |
Sep 2002 | - | $1.01M(-45.4%) | $3.86M(+9.2%) |
Jun 2002 | - | $1.85M(+85.5%) | $3.54M(+52.4%) |
Mar 2002 | - | $998.80K(+45.7%) | $2.32M(-12.6%) |
Dec 2001 | $3.05M(+72.2%) | - | - |
Aug 2001 | - | $685.30K(+7.5%) | $2.66M(+15.0%) |
May 2001 | - | $637.40K(-9.2%) | $2.31M(+8.0%) |
Feb 2001 | - | $701.60K(+11.1%) | $2.14M(+20.0%) |
Nov 2000 | $1.77M(+74.1%) | $631.70K(+86.8%) | $1.78M(+18.8%) |
Aug 2000 | - | $338.10K(-27.6%) | $1.50M(+10.1%) |
May 2000 | - | $467.20K(+35.6%) | $1.36M(+24.0%) |
Feb 2000 | - | $344.60K(-1.4%) | $1.10M(+7.8%) |
Nov 1999 | $1.02M(-25.5%) | $349.60K(+74.2%) | $1.02M(+52.2%) |
Aug 1999 | - | $200.70K(-1.4%) | $669.40K(+42.8%) |
May 1999 | - | $203.50K(-23.3%) | $468.70K(+76.7%) |
Feb 1999 | - | $265.20K | $265.20K |
Nov 1998 | $1.37M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual SGA year-on-year change?
- What is Aurinia Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly SGA year-on-year change?
- What is Aurinia Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM SGA year-on-year change?
What is Aurinia Pharmaceuticals annual SGA?
The current annual SGA of AUPH is $172.03M
What is the all time high annual SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual SGA is $196.37M
What is Aurinia Pharmaceuticals annual SGA year-on-year change?
Over the past year, AUPH annual SGA has changed by -$23.01M (-11.80%)
What is Aurinia Pharmaceuticals quarterly SGA?
The current quarterly SGA of AUPH is $20.34M
What is the all time high quarterly SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly SGA is $60.62M
What is Aurinia Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AUPH quarterly SGA has changed by -$27.36M (-57.36%)
What is Aurinia Pharmaceuticals TTM SGA?
The current TTM SGA of AUPH is -$3.74B
What is the all time high TTM SGA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM SGA is -$5.50M
What is Aurinia Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AUPH TTM SGA has changed by -$3.94B (-2004.07%)